NCT05762952View on ClinicalTrials.gov

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

August 5, 2025

Study Completion Date

March 31, 2026

Conditions
Myocardial Ischemia
Interventions
DRUG

Dapagliflozin 10mg Tab

Once daily oral dapagliflozin 10mg

DRUG

Placebo

Placebo capsules formulated by pharmacy to be indistinguishable from active drug

Trial Locations (1)

22908

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER